Aimovig

Aimovig

erenumab

Manufacturer:

Novartis

Distributor:

Zuellig
Concise Prescribing Info
Contents
Erenumab
Indications/Uses
Prophylaxis of migraine in adults who have at least 4 migraine days per mth.
Dosage/Direction for Use
SC 70 mg every 4 wk. Some patients may benefit from 140 mg every 4 wk.
Contraindications
Special Precautions
Patients w/ certain major CV diseases. Allergic reactions in individuals sensitive to latex. Pregnancy & lactation. Childn <18 yr.
Adverse Reactions
Inj site reactions, constipation, muscle spasms, pruritus.
ATC Classification
N02CD01 - erenumab ; Belongs to the class of calcitonin gene-related peptide (CGRP) antagonists preparations. Used to relieve migraine.
Presentation/Packing
Form
Aimovig soln for inj 70 mg/mL
Packing/Price
1's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign up for free
Already a member? Sign in